Details of the Drug Combinations

General Information of This Drug (ID: DMB9861)

Drug Name

Rilapladib DMB9861

Indication

Disease Entry	ICD 11	Status	REF
Arteriosclerosis	BD40	Phase 1	[1]
Cardiovascular disease	BA00-BE2Z	Phase 1	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Rilapladib + Itraconazole	DCQ3ZVG	Itraconazole	Alzheimer's Disease	[3]
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7376).
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018454)
3	ClinicalTrials.gov (NCT02130661) Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers